GlassScriptPhysician profile
Jacqueline Kreft
NPI 1619495082
$5,646.81
in general payments reported to CMS, 2019-2025
27 companies · $1,169 in 2025
The $1,169 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $641 · 2022: $1,179 · 2023: $911 · 2024: $1,747 · 2025: $1,169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,668 · Education: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,668.27 |
| Education | $158.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $736.04 | 2021-2025 | Watchman Flx, Eluvia, Watchman Access System |
| Pfizer INC. | $474.56 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $442.07 | 2022-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $405.65 | 2022-2025 | Lifevest |
| Medtronic, INC. | $396.39 | 2022-2025 | Corevalve Evolut R, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $392.63 | 2021-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Amgen INC. | $377.30 | 2021-2025 | Repatha |
| Actelion Pharmaceuticals US, INC. | $359.06 | 2024-2025 | Opsumit, Uptravi |
| Novartis Pharmaceuticals Corporation | $318.17 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $285.29 | 2022-2025 | Jardiance |
| Edwards Lifesciences Corporation | $244.54 | 2021-2025 | Pascal, Sapien 3 Ultra Resilia |
| Bayer Healthcare Pharmaceuticals INC. | $213.54 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $172.66 | 2022-2024 | Xarelto |
| Kiniksa Pharmaceuticals International, Plc | $137.65 | 2024 | Arcalyst |
| Abiomed | $119.13 | 2024 | Impella |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $99.99 | 2022 | |
| Esperion Therapeutics, INC. | $90.90 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $81.87 | 2024-2025 | Wainua, Brilinta |
| Philips North America LLC | $74.45 | 2023 | |
| Alnylam Pharmaceuticals INC. | $66.77 | 2025 | Onpattro |
| Angiodynamics, INC. | $38.78 | 2022 | |
| Bridgebio Pharma, INC. | $22.18 | 2025 | Attruby |
| Atricure, INC. | $20.89 | 2022 | |
| Sanofi-Aventis U.S. LLC | $20.60 | 2023 | |
| Kiniksa Pharmaceuticals, LTD. | $20.56 | 2023 | Arcalyst |
| Impulse Dynamics (USA) INC. | $20.25 | 2025 | Optimizer |
| Livanova USA, INC. | $14.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Kreft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.